Effectiveness of the medical chatbot PROSCA to inform patients about prostate cancer: results of a randomized controlled trial

Background and objective - Artificial intelligence (AI)-powered conversational agents are increasingly finding application in health care, as these can provide patient education at any time. However, their effectiveness in medical settings remains largely unexplored. This study aimed to assess the i...

Full description

Saved in:
Bibliographic Details
Main Authors: Baumgärtner, Kilian (Author) , Byczkowski, Michael (Author) , Schmid, Tamara (Author) , Muschko, Marc (Author) , Woessner, Philipp (Author) , Gerlach, Axel (Author) , Bonekamp, David (Author) , Schlemmer, Heinz-Peter (Author) , Hohenfellner, Markus (Author) , Görtz, Magdalena (Author)
Format: Article (Journal)
Language:English
Published: [17 September 2024]
In: European urology open science
Year: 2024, Volume: 69, Pages: 80-88
ISSN:2666-1683
DOI:10.1016/j.euros.2024.08.022
Online Access:Verlag, kostenfrei, Volltext: https://doi.org/10.1016/j.euros.2024.08.022
Verlag, kostenfrei, Volltext: https://www.sciencedirect.com/science/article/pii/S2666168324006554
Get full text
Author Notes:Kilian Baumgärtner, Michael Byczkowski, Tamara Schmid, Marc Muschko, Philipp Woessner, Axel Gerlach, David Bonekamp, Heinz-Peter Schlemmer, Markus Hohenfellner, Magdalena Görtz

MARC

LEADER 00000caa a2200000 c 4500
001 1920731091
003 DE-627
005 20250717003402.0
007 cr uuu---uuuuu
008 250327s2024 xx |||||o 00| ||eng c
024 7 |a 10.1016/j.euros.2024.08.022  |2 doi 
035 |a (DE-627)1920731091 
035 |a (DE-599)KXP1920731091 
035 |a (OCoLC)1528043888 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Baumgärtner, Kilian  |e VerfasserIn  |0 (DE-588)1361501588  |0 (DE-627)1920731385  |4 aut 
245 1 0 |a Effectiveness of the medical chatbot PROSCA to inform patients about prostate cancer  |b results of a randomized controlled trial  |c Kilian Baumgärtner, Michael Byczkowski, Tamara Schmid, Marc Muschko, Philipp Woessner, Axel Gerlach, David Bonekamp, Heinz-Peter Schlemmer, Markus Hohenfellner, Magdalena Görtz 
264 1 |c [17 September 2024] 
300 |a 9 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 27.03.2025 
520 |a Background and objective - Artificial intelligence (AI)-powered conversational agents are increasingly finding application in health care, as these can provide patient education at any time. However, their effectiveness in medical settings remains largely unexplored. This study aimed to assess the impact of the chatbot “PROState cancer Conversational Agent” (PROSCA), which was trained to provide validated support from diagnostic tests to treatment options for men facing prostate cancer (PC) diagnosis. - Methods - The chatbot PROSCA, developed by urologists at Heidelberg University Hospital and SAP SE, was evaluated through a randomized controlled trial (RCT). Patients were assigned to either the chatbot group, receiving additional access to PROSCA alongside standard information by urologists, or the control group (1:1), receiving standard information. A total of 112 men were included, of whom 103 gave feedback at study completion. - Key findings and limitations - Over time, patients’ information needs decreased significantly more in the chatbot group than in the control group (p = 0.035). In the chatbot group, 43/54 men (79.6%) used PROSCA, and all of them found it easy to use. Of the men, 71.4% agreed that the chatbot improved their informedness about PC and 90.7% would like to use PROSCA again. Limitations are study sample size, single-center design, and specific clinical application. - Conclusions and clinical implications - With the introduction of the PROSCA chatbot, we created and evaluated an innovative, evidence-based AI health information tool as an additional source of information for PC. Our RCT results showed significant benefits of the chatbot in reducing patients’ information needs and enhancing their understanding of PC. This easy-to-use AI tool provides accurate, timely, and accessible support, demonstrating its value in the PC diagnosis process. Future steps include further customization of the chatbot’s responses and integration with the existing health care systems to maximize its impact on patient outcomes. - Patient summary - This study evaluated an artificial intelligence-powered chatbot—PROSCA, a digital tool designed to support men facing prostate cancer diagnosis by providing validated information from diagnosis to treatment. Results showed that patients who used the chatbot as an additional tool felt better informed than those who received standard information from urologists. The majority of users appreciated the ease of use of the chatbot and expressed a desire to use it again; this suggests that PROSCA could be a valuable resource to improve patient understanding in prostate cancer diagnosis. 
650 4 |a Artificial intelligence 
650 4 |a Chatbot 
650 4 |a Early detection 
650 4 |a Large language model 
650 4 |a Natural language processing 
650 4 |a Prostate cancer 
650 4 |a Randomized controlled trial 
700 1 |a Byczkowski, Michael  |e VerfasserIn  |4 aut 
700 1 |a Schmid, Tamara  |e VerfasserIn  |4 aut 
700 1 |a Muschko, Marc  |e VerfasserIn  |4 aut 
700 1 |a Woessner, Philipp  |e VerfasserIn  |4 aut 
700 1 |a Gerlach, Axel  |e VerfasserIn  |4 aut 
700 1 |a Bonekamp, David  |d 1977-  |e VerfasserIn  |0 (DE-588)128868104  |0 (DE-627)383668581  |0 (DE-576)297371797  |4 aut 
700 1 |a Schlemmer, Heinz-Peter  |d 1961-  |e VerfasserIn  |0 (DE-588)1025559967  |0 (DE-627)722927142  |0 (DE-576)17334805X  |4 aut 
700 1 |a Hohenfellner, Markus  |d 1958-  |e VerfasserIn  |0 (DE-588)133862518  |0 (DE-627)557857988  |0 (DE-576)300155263  |4 aut 
700 1 |a Görtz, Magdalena  |d 1992-  |e VerfasserIn  |0 (DE-588)1166813657  |0 (DE-627)1030681392  |0 (DE-576)510916600  |4 aut 
773 0 8 |i Enthalten in  |t European urology open science  |d [Amsterdam] : Elsevier ScienceDirect, 2020  |g 69(2024), Seite 80-88  |h Online-Ressource  |w (DE-627)1734491795  |w (DE-600)3040546-4  |x 2666-1683  |7 nnas  |a Effectiveness of the medical chatbot PROSCA to inform patients about prostate cancer results of a randomized controlled trial 
773 1 8 |g volume:69  |g year:2024  |g pages:80-88  |g extent:9  |a Effectiveness of the medical chatbot PROSCA to inform patients about prostate cancer results of a randomized controlled trial 
856 4 0 |u https://doi.org/10.1016/j.euros.2024.08.022  |x Verlag  |x Resolving-System  |z kostenfrei  |3 Volltext 
856 4 0 |u https://www.sciencedirect.com/science/article/pii/S2666168324006554  |x Verlag  |z kostenfrei  |3 Volltext 
951 |a AR 
992 |a 20250327 
993 |a Article 
994 |a 2024 
998 |g 1166813657  |a Görtz, Magdalena  |m 1166813657:Görtz, Magdalena  |d 910000  |d 910200  |d 50000  |e 910000PG1166813657  |e 910200PG1166813657  |e 50000PG1166813657  |k 0/910000/  |k 1/910000/910200/  |k 0/50000/  |p 10  |y j 
998 |g 133862518  |a Hohenfellner, Markus  |m 133862518:Hohenfellner, Markus  |d 910000  |d 910200  |e 910000PH133862518  |e 910200PH133862518  |k 0/910000/  |k 1/910000/910200/  |p 9 
998 |g 128868104  |a Bonekamp, David  |m 128868104:Bonekamp, David  |d 50000  |d 910000  |d 911100  |e 50000PB128868104  |e 910000PB128868104  |e 911100PB128868104  |k 0/50000/  |k 0/910000/  |k 1/910000/911100/  |p 7 
999 |a KXP-PPN1920731091  |e 4694712608 
BIB |a Y 
SER |a journal 
JSO |a {"physDesc":[{"extent":"9 S."}],"origin":[{"dateIssuedKey":"2024","dateIssuedDisp":"[17 September 2024]"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"language":["eng"],"title":[{"subtitle":"results of a randomized controlled trial","title_sort":"Effectiveness of the medical chatbot PROSCA to inform patients about prostate cancer","title":"Effectiveness of the medical chatbot PROSCA to inform patients about prostate cancer"}],"name":{"displayForm":["Kilian Baumgärtner, Michael Byczkowski, Tamara Schmid, Marc Muschko, Philipp Woessner, Axel Gerlach, David Bonekamp, Heinz-Peter Schlemmer, Markus Hohenfellner, Magdalena Görtz"]},"note":["Gesehen am 27.03.2025"],"id":{"doi":["10.1016/j.euros.2024.08.022"],"eki":["1920731091"]},"person":[{"family":"Baumgärtner","role":"aut","given":"Kilian","display":"Baumgärtner, Kilian","roleDisplay":"VerfasserIn"},{"given":"Michael","display":"Byczkowski, Michael","roleDisplay":"VerfasserIn","role":"aut","family":"Byczkowski"},{"role":"aut","family":"Schmid","display":"Schmid, Tamara","roleDisplay":"VerfasserIn","given":"Tamara"},{"role":"aut","family":"Muschko","given":"Marc","display":"Muschko, Marc","roleDisplay":"VerfasserIn"},{"roleDisplay":"VerfasserIn","display":"Woessner, Philipp","given":"Philipp","family":"Woessner","role":"aut"},{"role":"aut","family":"Gerlach","given":"Axel","roleDisplay":"VerfasserIn","display":"Gerlach, Axel"},{"given":"David","roleDisplay":"VerfasserIn","display":"Bonekamp, David","role":"aut","family":"Bonekamp"},{"role":"aut","family":"Schlemmer","roleDisplay":"VerfasserIn","display":"Schlemmer, Heinz-Peter","given":"Heinz-Peter"},{"role":"aut","family":"Hohenfellner","display":"Hohenfellner, Markus","roleDisplay":"VerfasserIn","given":"Markus"},{"display":"Görtz, Magdalena","roleDisplay":"VerfasserIn","given":"Magdalena","role":"aut","family":"Görtz"}],"recId":"1920731091","relHost":[{"title":[{"title_sort":"European urology open science","title":"European urology open science"}],"note":["Gesehen am 23. September 2021"],"disp":"Effectiveness of the medical chatbot PROSCA to inform patients about prostate cancer results of a randomized controlled trialEuropean urology open science","id":{"issn":["2666-1683"],"zdb":["3040546-4"],"eki":["1734491795"]},"pubHistory":["Volume 19, supplement 1 (January 2020)-"],"recId":"1734491795","part":{"volume":"69","text":"69(2024), Seite 80-88","extent":"9","year":"2024","pages":"80-88"},"type":{"media":"Online-Ressource","bibl":"periodical"},"origin":[{"dateIssuedDisp":"2020-","publisher":"Elsevier ScienceDirect","dateIssuedKey":"2020","publisherPlace":"[Amsterdam]"}],"physDesc":[{"extent":"Online-Ressource"}],"language":["eng"]}]} 
SRT |a BAUMGAERTNEFFECTIVEN1720